Colin Hislop

2012 - Anthera Pharmaceuticals

In 2012, Colin Hislop earned a total compensation of $539.6K as Chief Medical Officer at Anthera Pharmaceuticals, a 31% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$24,441
Option Awards$107,384
Salary$347,500
Stock Awards$60,314
Total$539,639

Hislop received $347.5K in salary, accounting for 64% of the total pay in 2012.

Hislop also received $24.4K in non-equity incentive plan, $107.4K in option awards and $60.3K in stock awards.

Rankings

In 2012, Colin Hislop's compensation ranked 8,526th out of 11,487 executives tracked by ExecPay. In other words, Hislop earned more than 25.8% of executives.

ClassificationRankingPercentile
All
8,526
out of 11,487
26th
Division
Manufacturing
3,096
out of 4,253
27th
Major group
Chemicals And Allied Products
826
out of 1,198
31st
Industry group
Drugs
601
out of 920
35th
Industry
Pharmaceutical Preparations
471
out of 700
33rd
Source: SEC filing on April 9, 2015.

Hislop's colleagues

We found five more compensation records of executives who worked with Colin Hislop at Anthera Pharmaceuticals in 2012.

2012

Paul Truex

Anthera Pharmaceuticals

Chief Executive Officer

2012

Debra Odink

Anthera Pharmaceuticals

Chief Technology Officer

2012

Christopher Lowe

Anthera Pharmaceuticals

Chief Financial Officer

2012

Georgina Kilfoil

Anthera Pharmaceuticals

Senior Vice President, Product Development

2012

May Liu

Anthera Pharmaceuticals

Senior Vice President, Finance & Administration

You may also like